Roger Md Medel - Jan 10, 2022 Form 4 Insider Report for MEDNAX, INC. (MD)

Role
Director
Signature
/s/ Dominic J. Andreano, Attorney-in-Fact
Stock symbol
MD
Transactions as of
Jan 10, 2022
Transactions value $
-$2,649,615
Form type
4
Date filed
1/11/2022, 05:00 PM
Previous filing
Jan 7, 2022
Next filing
May 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MD Common Stock Sale -$1.58M -59.9K -7.13% $26.44 780K Jan 10, 2022 Direct F1, F2
transaction MD Common Stock Sale -$1.07M -40.1K -5.14% $26.58 739K Jan 11, 2022 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sales made pursuant to reporting person's 10b5-1 trading plan adopted August 25, 2021.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.04 to $26.75 for a weighted average sales price of $26.44. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.14 to $26.96 for a weighted average sales price of $26.58. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.